An overview of the adverse reactions to adrenal corticosteroids

Adverse Drug Reactions and Toxicological Reviews

Volumn 15, Issue 4, 1996, Pages 203-206

  Frauman, Albert G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adrenal corticosteroids; Adverse reactions; Glucocorticoids; Mineralocorticoids

Indexed keywords

CALCIUM; CORTICOSTEROID; GLUCOCORTICOID; MINERALOCORTICOID; VITAMIN D;

ASTHMA; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG THERAPY; ECZEMA; ELECTROLYTE DISTURBANCE; HUMAN; MOLECULAR BIOLOGY; OSTEOPOROSIS; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTEBRA FRACTURE;

ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OSTEOPOROSIS; WATER-ELECTROLYTE BALANCE;

EID: 0030426743     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Ing NH, O'Malley BW. The Steroid Hormone Receptor Superfamily: Molecular Mechanisms of Action. From: Molecular Endocrinology: Basic Concepts and Clinical Correlations pp. 195-215. Ed B. D. Weintraub (Raven Press, New York, 1995).
2. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin. Pharmacol. 1993; 45(suppl. 1):S3-S7.
3. Schimmer BP, Parker KL. Adrenocorticotrophic Hormone: Adrenocortical Steroids and their Synthetic Analogs; Inhibitors of the Synthesis and Actions of Adrenocortical Hormones. In Goodman and Gilman. The Pharmacological Basis of Therapeutics. pp. 1459-85. Eds JG Hardman and LE Limbard (McGraw Hill, New York, 1996).
4. Seale JP, Compton MR. Side-effects of corticosteroid agents. Med. J. Aust. 1986; 144: 139-42.
5. Shane E, Epstein S. Immunosuppressive therapy and the skeleton. Trends Endocrinol. Metab. 1994; 5: 169-75.
6. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J. Clin. Endocrinol. Metab. 1991; 72: 382-6.
7. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann. Int. Med. 1990; 112: 352-64.
8. Dempster DW. Perspectives: bone histomorphometry in glucocorticoid-induced osteoporosis. J. Bone Mineral Res. 1989; 4: 137-41.
9. Lo Cascio V, Bonucei E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G, Fuccella L, Adami S. Bone loss after glucocorticoid therapy. Calcif. Tiss Int. 1984; 36: 435-8.
10. Martin TJ, Allan EH, Manji S, Zhou H, Ng KW. Glucocorticoid actions on bone formation. A cell biology perspective. Endo. Soc. Aust. Annual Meeting 1994 Abstract 171.
11. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol and calcitonin. N. Eng. J. Med. 1993; 328: 1747-52.
12. Ebeling PR. Pathogenesis of steroid-induced osteoporosis. Endo. Soc. Aust. Annual Meeting. 1994 Abstract 173.